Lyntris Inc. <LYNX.N>: Raymond James initiates coverage with outperform rating; price target $18
LYNX•Related News
Nasus Pharma wins FDA clearance to start NS002 anaphylaxis study
NSRX•
Genius Sports CEO says US sports wagering demand persists as prediction market rules evolve
GENI•
Dollar rallies as oil prices jump and AI fears knock markets
UUP•
Baird Medical showcases microwave ablation system at CIRSE 2026 congress in Copenhagen
BDMD•
Energy Recovery, Inc. <ERII.O>: Seaport Research Partners cuts to Neutral from Buy
ERII•